Plasma Peptide Biomarker Discovery for Amyotrophic Lateral Sclerosis by MALDI –TOF Mass Spectrometry Profiling

The diagnostic of Amyotrophic lateral sclerosis (ALS) remains based on clinical and neurophysiological observations. The actual delay between the onset of the symptoms and diagnosis is about 1 year, preventing early inclusion of patients into clinical trials and early care of the disease. Therefore,...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Conraux, Laurence, Pech, Catherine, Guerraoui, Halim, Loyaux, Denis, Ferrara, Pascual, Guillemot, Jean-Claude, Meininger, Vincent, Pradat, Pierre-François, Salachas, François, Bruneteau, Gaëlle, Le Forestier, Nadine, Lacomblez, Lucette
Format: Artigo
Idioma:Inglês
Publicat: Public Library of Science 2013
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3818176/
https://ncbi.nlm.nih.gov/pubmed/24224000
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0079733
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars